NIH Grant Will Test Therapeutic Approach for CLN3 Batten Disease
Michelle Hastings, PhD, was awarded a grant to discover treatments for CLN3 Batten disease, a fatal neurodegenerative…
News Archive
Announcing Key Recruitments to the Brain Science Institute
Dr. Eun Jung Hwang and Dr. Sarah Johnson officially join RFU as tenure track assistant professors in CMS’s Department…
Fostering Excellence in Biomedical Research
Kelly Wilson, SGPS ’21, a graduate research assistant in the lab of Dr. Johnny He, director of the Center for Cancer…
Collaborating Across Systems
Strong collaboration across universities, health systems and the federal government is speeding the national Expanded…
Investing in Innovation
Helix 51 incubator company Inspirotec announced in March that its commercially available air sampling device (AirAnswers™)…
Promising Research on Batten Disease Therapeutic Approach Advances at RFU's Center for Genetic Disease
Researchers led by a team at Rosalind Franklin University of Medicine and Science have devised a…
Rosalind Franklin University Biomedical Incubator Gains Support from AbbVie
Rosalind Franklin University of Medicine and Science announced today that its new Helix 51 incubator…
Innovation and Research Park Opens
Our new Innovation and Research Park (IRP), which opened this past winter, underscores our commitment to scientific…
RFU Collaborates With Exicure to Identify New Therapeutics for Genetic Diseases
A research collaboration between the university’s Center for Genetic Diseases and the Chicagoland…
Helix 51 Incubator Gains Support from Horizon Therapeutics
The university’s Helix 51 incubator has garnered corporate support from Horizon Therapeutics.
The first bioscience…